Tempus AI Bets Big on Whole-Genome Data as Stock Surges Despite Path to Profitability Remains Unclear

Tempus AI Bets Big on Whole-Genome Data as Stock Surges Despite Path to Profitability Remains Unclear | Health AI Central | Health AI Central